U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07631000) titled 'A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer' on June 01.
Brief Summary: The purpose of this study is to find out whether adding cadonilimab to the usual chemotherapy approach is an effective and safe treatment for participants with locally advanced/resectable gastric cancer or gastroesophageal junction (GEJ) cancer
Study Start Date: May 27
Study Type: INTERVENTIONAL
Condition:
Gastric Cancer
Gastroesophageal-junction Cancer
Intervention:
DRUG: Cadonilimab
Perioperative cadonilimab plus neoadjuvant chemotherapy
Recruitment Status: RECRUITING
Sponsor: Memorial Sl...